NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/27/2025
Back to search
Official data from USPTO
NOBELPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOBELPHARMA
ST13
US500000087122899Class
5, 10, 44
Filing
87122899
Registration
5552898
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/16/2025
Trademark type
Word
Nice classes
5, 10, 44
Filing date
08/01/2016
Registration date
09/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/27/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Tokyo, JP
Examiner
CASE, LEIGH
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nobelpharma Co., Ltd.
Nobelpharma Co., Ltd.
Representatives
Sandra Epp Ryan HSML P.C.
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; pharmaceutical preparations for treating skin disorders; vaccines; vaccines for treating malaria
Class 10
Medical apparatus and instruments for treating spasmodic dysphonia; medical apparatus and instruments for type 2 thyroplasty
Class 44
Providing medical information; providing pharmaceutical information; medical and pharmaceutical consultation
Publications
History of USPTO decisions and trademark events.
26 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
03/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2025
ES8R
TEAS SECTION 8 RECEIVED
08/21/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/19/2018
PUBO
PUBLISHED FOR OPPOSITION
06/19/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/30/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/04/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/30/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/28/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/29/2017
ALIE
ASSIGNED TO LIE
11/29/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/22/2017
GNSL
LETTER OF SUSPENSION E-MAILED
05/22/2017
CNSL
SUSPENSION LETTER WRITTEN
05/22/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/17/2016
GNRT
NON-FINAL ACTION E-MAILED
11/17/2016
CNRT
NON-FINAL ACTION WRITTEN
11/17/2016
DOCK
ASSIGNED TO EXAMINER
11/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2016
NWAP
NEW APPLICATION ENTERED
08/04/2016
Continuous trademark protection
Get notified about every new filing that threatens NOBELPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.